Cancer Clinical Trials
Almost everything we know about how to diagnose and treat cancer today was learned through the participation of people just like you. You can make a difference for future cancer patients by taking part in a clinical trial.
Your provider will discuss whether a clinical trial is available to you. Enrolling is your choice. You may choose to take part or not and are free to leave at any time.
See our open cancer clinical trials below. For more information, including how to enroll, please call 609-677-7735.
To learn more about clinical trials, visit the National Cancer Institute site.
Active Clinical Trials
Brain Cancer
CCTG CE.7
Category
Brain Cancer
Full Name
Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5-15 Brain Metastases
Brief Description
A Phase III Trial of Stereotactic Radiosurgery Compared with Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) plus Memantine for 5 – 15 brain metastases
Sponsor
NCI Sponsored
Breast Cancer
S2010
Category
Breast Cancer
Full Name
Monitoring Symptoms to Help Young Women Take Hormone Therapy for Stage I-III Breast Cancer, ASPEN Study
Brief Description
A Randomized Phase III Trial Comparing Active Symptom Monitoring Plus Patient Education Versus Patient Education Alone to Improve Persistence With Endocrine Therapy in Young Women With Stage I-III Breast Cancer (ASPEN)
Sponsor
SWOG Sponsored
Genitourinary Cancer
A031704
Category
Genitourinary Cancer
Full Name
Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer, The PDIGREE Study
Brief Description
PD-Inhibitor (Nivolumab) & Ipilimumab followed by Nivolumab vs VEGF TKI Cabozantinib with Nivolumab: A Phase III Trial in Metastatic Untreatet Renal Cell Cancer (PDIGREE)
Sponsor
NCI Sponsored
Head & Neck Cancer
EA3161
Category
Head & Neck Cancer
Full Name
Testing Immunotherapy Versus Observation in Patients With HPV Throat Cancer
Brief Description
A Phase II/III Randomized Study of Maintenance Nivolumab versus Observation in Patients with Locally Advanced, Intermediate-Risk HPV Positive Oropharyngeal Cancer
Sponsor
NCI Sponsored
Multiple Disease Sites
Research Patient Registry
Category
Multiple Disease Sites
Full Name
RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT
Brief Description
A research registry of the de-identified treatment and follow-up data of patients receiving stereotactic radiosurgery (SRS)/stereotactic body radiation therapy (SBRT), including CyberKnife (CK)
Sponsor
Industry Sponsored
Prostate
NRG-GU010
Category
Prostate Cancer
Full Name
Two Studies for Patients with Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients with a Low Gene Risk Score and Testing a More Intense Treatment for Patients with a Higher Gene Risk Score.
Brief Description
Parallel Phase III Randomized Trials of Genomic-Risk Stratified Unfavorable Intermediate Risk Prostate Cancer: De-Intensification and Intensification Clinical Trial Evaluation (GUIDANCE)
Sponsor
NRG Oncology
OPTYX Registry
Category
Prostate Cancer
Full Name
A Multi-Center, Prospective, Observational Study of Patients Being Treated With ORGOVYX (OPTYX).
Brief Description
The goal of this study is to generate real-world evidence about the safety and effectiveness of ORGOVYX in patients with prostate cancer in routine clinical care and the clinical course during treatment with and following cessation of ORGOVYX.
Sponsor
Myovant Sciences GmbH
NRG-GU009
Category
Prostate Cancer
Full Name
Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT Trial
Brief Description
Parallel Phase III Randomized Trials for High Risk Prostate Cancer Evaluating De-Intensification for Lower Genomic Risk and Intensification of Concurrent Therapy for Higher Genomic Risk With Radiation (PREDICT-RT*)
Sponsor
NRG Oncology